He Cao (曹赫)
I am currently a Senior Director of AI R&D at Immunocan, where I work on advancing AI for antibody drug discovery and antibody engineering. Previously, I was an AI for Science Researcher at the CTO Lab, International Digital Economy Academy (IDEA), working closely with Dr. Zijing Liu, Ziqi Gao, and Yu Li.
My research lies at the intersection of foundation models, scientific reasoning, and autonomous agents. I am particularly interested in building multimodal and agentic AI systems for scientific discovery, as well as developing reliable methods to evaluate their reasoning and problem-solving capabilities, with applications to chemistry, biology, and drug discovery.
My work aims to build scientifically grounded AI systems that can understand, reason over, and act on complex scientific data. I develop multimodal and agentic methods that connect natural language with molecular structures, chemical reactions, proteins, and drug-discovery workflows. More recently, I have focused on scientific foundation models, trustworthy evaluation and alignment, and autonomous agents for scientific research.
Earlier in my research, I worked on generative vision and multimodal learning, including diffusion models, 3D generation, and open-world visual understanding. These experiences shaped my broader perspective on foundation models and multimodal intelligence, and ultimately motivated my transition toward AI for Science and scientific discovery.
I received my Ph.D. (2020–2025) from the Individualized Interdisciplinary Program in Artificial Intelligence at The Hong Kong University of Science and Technology, advised by Prof. Yuan Yao and Prof. Yangqiu Song. Before that, I received my B.S. (2016–2020) in Computer Science and Technology from Harbin Institute of Technology (Shenzhen).
Research Interests
- Reliable scientific foundation models: multimodal representation learning and reasoning over molecules, chemical reactions, proteins, protein-ligand systems, and scientific literature.
- Evaluation and alignment for scientific LLMs: factuality, hallucination, chemical reasoning, reaction-diagram understanding, safety, preference alignment, and process-level verification.
- Agentic AI for drug discovery: governed tool use, workflow orchestration, human-in-the-loop scientific agents, and auditable autonomous discovery systems.
- Generative modeling for science and vision: diffusion and autoregressive models for molecular, protein, visual, and 3D generation.
Experience
2026 - Present
Senior Director of AI R&D, Immunocan
2025 - 2026
Researcher, AI for Science Team, CTO-Lab, IDEA
2022 - 2025
Algorithm Research Intern, IDEA
Services
Reviewer
ICLR, AAAI, CVPR, ACL, NeurIPS, EMNLP, ICML, ECCV.
2021 - 2025
Graduate Teaching Assistant
AI for Fintech Courses, Department of Mathematics, HKUST.